Breaking News

Bharat Biotech

Ambani says will provide technology tools for COVID-19 vaccination drive

8:27 pm December 15, 2020

New Delhi: As India gets ready to roll out one of the largest vaccine programmes, billionaire Mukesh Ambani on Tuesday said his group is working with authorities to provide technology tools and backbone for mass inoculation against COVID-19. Ambani’s telecom venture Jio was rolled out four years back, offering free voice calling and dirt-cheap data. Today, Jio is India’s largest telecom […]

Read More
Delhi has less than a day’s stock of Covaxin for 45-plus age group: Atishi

Bharat Biotech’s intranasal COVID-19 vaccine to enter phase 1 trials next month

11:31 pm December 8, 2020

Hyderabad: Bharat Biotech is expected to initiate Phase-1 trials of its intranasal vaccine for COVID-19 next month, Krishna Ella, Chairman and Managing Director Of the city-base vaccine maker said on Tuesday. Speaking at a session of the three-day TiE Global Summit (TGS)being held virtually,he said Bharat Biotech is setting up two more facilities for vaccine […]

Read More
Delhi has less than a day’s stock of Covaxin for 45-plus age group: Atishi

Bharat Biotech seeks emergency use authorisation for indigenously developed COVID-19 vaccine Covaxin

11:51 pm December 7, 2020

New Delhi: After Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech on Monday applied to the central drug regulator seeking emergency use authorisation for its COVID-19 vaccine Covaxin, official sources said. Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). On December 4, Prime Minister Narendra Modi at an all-party meeting had expressed hope that a […]

Read More
Delhi has less than a day’s stock of Covaxin for 45-plus age group: Atishi

Covaxin Phase-3 trials begins in Karnataka

7:37 pm December 2, 2020

Bengaluru: Karnataka is fully prepared for the distribution of COVID-19 vaccine, Health and Medical Education Minister K Sudhakar said on Wednesday, as phase-III clinical trial of “Covaxin” being developed by Bharat Biotech began in the state. The minister said it was a matter of pride for the state with clinical trials taking place at 25 centres of 12 states across the […]

Read More

In process to apply for emergency use licensure for COVID-19 vaccine: Adar Poonawalla

10:23 pm November 28, 2020

New Delhi: Vaccine major Serum Institute of India (SII) on Saturday said it is in the process of applying for an emergency use licensure for the AstraZeneca-Oxford’s COVID-19 vaccine candidate in India in the next two weeks. Addressing a virtual press conference on the visit of Prime Minister Narendra Modi to the company’s Pune facility, Serum Institute […]

Read More
Powered by WordPress | Bootstrap Themes